Company
Eden Research PLC
LON:EDEN
Eden Research PLC is the UK’s only AIM listed company focused on biopesticides for sustainable agriculture. The company develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries. Its vision is to be a global leader in sustainable crop protection through the development of bioactive products enabled or enhanced by our novel encapsulation and delivery technologies.
170 stories · page 3 of 9
Eden Research gets approval from California and Florida for its biopesticides
"California and Florida are amongst the most significant addressable markets in the US considering their production of high-value crops"
Eden Research receives regulatory green light in Poland for key product
Approval for Mevalone marks start of push into Central Europe
Eden Research first-half revenue grows 32%; on track to meet full-year sales guidance
The sustainable biopesticides group has “materially” increased its global addressable market with label extensions and new regulatory approvals
Eden Research shares soar as investors cheer ‘significant achievement’
An environmental approval in the United States has significantly boosted Eden's commercial prospects.
Eden Research wins US EPA approval in boost for insecticide plans
All five petitions for the AIM-quoted company’s active ingredients and formulated products get the nod from the US regulator
Eden Research appoints non-exec director with over 25 years of experience
Richard Horsman has delivered both organic and acquisition-based growth that will support the company in delivering on its strategic objectives
Eden Research says it is on target to meet full-year expectations after strong first half
The sustainable biopesticides group also spelled out the scale of the potential opportunity in the US
Eden Research upbeat on current year and expects return to stronger growth
"Eden has continued to make positive strides that have seen us lay down firm foundations for revenue growth,” chairman Lykele van der Broek said
Eden Research looks to build on progress made in 2021
The update was provided alongside the company's full-year results
Eden Research moves closer to US regulatory success
It has passed what it describes as a "key milestone" with the Environmental Protection Agency
Eden Research gets buy rating from Cenkos after broadening market opportunities during pandemic
The broker forecasts revenue from Mevalone and Cedroz will rise from the £1.4mln reported in 2021 to £1.7mln in 2022 and £2.8mln in 2023